Debate Over BMS Versus DES in High-bleeding-risk Scenarios Gets Fresh Fuel in Meta-analysis
In patients at high bleeding risk undergoing percutaneous coronary intervention, implantation with certain drug-eluting stents optimized for biocompatibility is associated with lower rates of MACE and other endpoints compared with bare-metal stents even with only one month of dual antiplatelet therapy, according to a new meta-analysis. The authors argue that the results once again question the appropriateness of using bare metal stents in this population moving forward.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063